Cargando…
Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials
Neurodegenerative diseases are caused by the gradual loss of neurons’ function. These neurological illnesses remain incurable, and current medicines only alleviate the symptoms. Given the social and economic burden caused by the rising frequency of neurodegenerative diseases, there is an urgent need...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860553/ https://www.ncbi.nlm.nih.gov/pubmed/36678841 http://dx.doi.org/10.3390/pharmaceutics15010212 |
_version_ | 1784874611779829760 |
---|---|
author | Andrade, Stéphanie Nunes, Débora Dabur, Meghna Ramalho, Maria J. Pereira, Maria C. Loureiro, Joana A. |
author_facet | Andrade, Stéphanie Nunes, Débora Dabur, Meghna Ramalho, Maria J. Pereira, Maria C. Loureiro, Joana A. |
author_sort | Andrade, Stéphanie |
collection | PubMed |
description | Neurodegenerative diseases are caused by the gradual loss of neurons’ function. These neurological illnesses remain incurable, and current medicines only alleviate the symptoms. Given the social and economic burden caused by the rising frequency of neurodegenerative diseases, there is an urgent need for the development of appropriate therapeutics. Natural compounds are gaining popularity as alternatives to synthetic drugs due to their neuroprotective properties and higher biocompatibility. While natural compounds’ therapeutic effects for neurodegenerative disease treatment have been investigated in numerous in vitro and in vivo studies, only few have moved to clinical trials. This article provides the first systematic review of the clinical trials evaluating natural compounds’ safety and efficacy for the treatment of the five most prevalent neurodegenerative disorders: Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and Huntington’s disease. |
format | Online Article Text |
id | pubmed-9860553 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98605532023-01-22 Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials Andrade, Stéphanie Nunes, Débora Dabur, Meghna Ramalho, Maria J. Pereira, Maria C. Loureiro, Joana A. Pharmaceutics Review Neurodegenerative diseases are caused by the gradual loss of neurons’ function. These neurological illnesses remain incurable, and current medicines only alleviate the symptoms. Given the social and economic burden caused by the rising frequency of neurodegenerative diseases, there is an urgent need for the development of appropriate therapeutics. Natural compounds are gaining popularity as alternatives to synthetic drugs due to their neuroprotective properties and higher biocompatibility. While natural compounds’ therapeutic effects for neurodegenerative disease treatment have been investigated in numerous in vitro and in vivo studies, only few have moved to clinical trials. This article provides the first systematic review of the clinical trials evaluating natural compounds’ safety and efficacy for the treatment of the five most prevalent neurodegenerative disorders: Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and Huntington’s disease. MDPI 2023-01-07 /pmc/articles/PMC9860553/ /pubmed/36678841 http://dx.doi.org/10.3390/pharmaceutics15010212 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Andrade, Stéphanie Nunes, Débora Dabur, Meghna Ramalho, Maria J. Pereira, Maria C. Loureiro, Joana A. Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials |
title | Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials |
title_full | Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials |
title_fullStr | Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials |
title_full_unstemmed | Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials |
title_short | Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials |
title_sort | therapeutic potential of natural compounds in neurodegenerative diseases: insights from clinical trials |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860553/ https://www.ncbi.nlm.nih.gov/pubmed/36678841 http://dx.doi.org/10.3390/pharmaceutics15010212 |
work_keys_str_mv | AT andradestephanie therapeuticpotentialofnaturalcompoundsinneurodegenerativediseasesinsightsfromclinicaltrials AT nunesdebora therapeuticpotentialofnaturalcompoundsinneurodegenerativediseasesinsightsfromclinicaltrials AT daburmeghna therapeuticpotentialofnaturalcompoundsinneurodegenerativediseasesinsightsfromclinicaltrials AT ramalhomariaj therapeuticpotentialofnaturalcompoundsinneurodegenerativediseasesinsightsfromclinicaltrials AT pereiramariac therapeuticpotentialofnaturalcompoundsinneurodegenerativediseasesinsightsfromclinicaltrials AT loureirojoanaa therapeuticpotentialofnaturalcompoundsinneurodegenerativediseasesinsightsfromclinicaltrials |